Article

Neuroethical Issues In Early Detection Of Alzheimer’S Disease

Marilyn S. Albert and Guy M. Mckhann

in Oxford Handbook of Neuroethics

Published in print April 2011 | ISBN: 9780199570706
Published online November 2012 | | DOI: http://dx.doi.org/10.1093/oxfordhb/9780199570706.013.0135

Series: Oxford Library of Psychology

 Neuroethical Issues In Early Detection Of Alzheimer’S Disease

More Like This

Show all results sharing these subjects:

  • Psychology
  • Cognitive Neuroscience
  • Clinical Psychology

GO

Show Summary Details

Preview

Neuroethical issues in the early detection of Alzheimer's disease (AD) are likely to be characteristic of any disorder where the boundary conditions between being impaired and unimpaired are unclear. Initial research efforts were focused on examining patients with established disease. The article discusses some challenges for the clinical diagnosis of mild cognitive impairment. The overarching ethical concern is that the term mild cognitive impairment (MCI) is being applied to patients in clinical settings, when the majority of the data pertains to risk for groups of subjects, as opposed to individuals. These same challenges regarding the boundary between normal and abnormal, and the probabilistic nature of predicting progression, apply to individuals with normal cognition. This balance between risks and benefits would, of course, change, when disease-modifying therapies are identified. Then potentially beneficial treatments could be instituted even when someone is cognitively normal.

Keywords: neuroethical issues; mild cognitive impairment; Alzheimer's disease; disease-modifying therapies; clinical settings

Article.  4069 words. 

Subjects: Psychology ; Cognitive Neuroscience ; Clinical Psychology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.